期刊文献+

氢吗啡酮和舒芬太尼用于术后静脉自控镇痛比较的meta分析 被引量:2

Meta-analysis of comparison between hydromorphone and sufentanil in postoperative intravenous controlled analgesia
下载PDF
导出
摘要 目的探讨氢吗啡酮和舒芬太尼在患者静脉自控镇痛的临床疗效。方法检索PubMed、Cochrane Library、中国生物医药、中国知网、万方、维普等数据库至2020年10月30日,收集氢吗啡酮和舒芬太尼用于患者静脉自控镇痛比较的文献,经文献筛选、资料提取及评价文献质量后,采用Revman 5.2软件进行统计学分析。结局指标包括术后疼痛评分、镇静评分、术后恶心呕吐、皮肤瘙痒和呼吸抑制发生率。结果总共纳入14篇研究,共1161名患者。结果显示:老年患者使用氢吗啡酮的术后镇痛效果优于舒芬太尼,差异有统计学意义(MD=-1.13,95%CI=-1.76~-0.50,P=0.0005),非老年患者使用氢吗啡酮或者舒芬太尼差别无统计学意义(MD=0.19,95%CI=-0.10~0.48,P=0.20)。与舒芬太尼相比,患者静脉自控镇痛使用氢吗啡酮的术后镇静程度、恶心呕吐及皮肤瘙痒发生率方面差异无统计学意义(MD=-0.16,95%CI=-0.47~0.15,P=0.31,OR=0.83,95%CI=0.53~1.30,P=0.42;OR=0.95,95%CI=0.45~2.04,P=0.9),但能降低呼吸抑制发生率,差别有统计学意义(OR=0.28,95%CI=0.11~0.72,P=0.008)。结论相比舒芬太尼,老年患者静脉自控镇痛使用氢吗啡酮在镇痛方面有一定优势,且能降低呼吸抑制发生率。 Objective To evaluate the patient controlled intravenous analgesia effect between hydromorphone and sufentanil.Methods PubMed,Cochrane Library,CBM,CNKI,Wanfang Database,and VIP Database(by October 30,2020)were searched for citations comparing hydromorphone and sufentanil for the patient controlled intravenous analgesia.After screening the citations,extracting data,and evaluating the quality,Revman 5.2 software was used for statistical data analysis.The outcomes included pain score,sedation score,the incidence of nausea and vomiting,itching,and respiratory depression during postoperative.Results A total of 14 studies involving 1161 patients were included.The results showed that the postoperative analgesic effect of hydromorphone was better than that of sufentanil in the elderly,with statistically significant difference(MD=-1.13,95%CI=-1.76--0.50,P=0.0005),and there was no difference in the younger(MD=0.19,95%CI=-0.10-0.48,P=0.20).Compared with sufentanil,PCIA with hydromorphone showed no significant difference in the incidence of postoperative sedation,nausea and vomiting,and itching(MD=-0.16,95%CI=-0.47-0.15,P=0.31,OR=0.83,95%CI=0.53-1.30,P=0.42;OR=0.95,95%CI=0.45-2.04,P=0.9),but lowered the incidence of respiratory depression,with statistically significant difference(OR=0.28,95%CI=0.11-0.72,P=0.008).Conclusion Compared with sufentanil,PCIA with hydromorphone has a better analgesic effect in the elderly,and reduce the incidence of respiratory depression.
作者 范杏 刘慧 潘冰冰 FAN Xing;LIU Hui;PAN Bing-bing(Department of Anesthesiology,Hu′nan Provincial People′s Hospital,the First Affliated Hospital of Hu′nan Normal University,Clinical Research Center for Anesthesiology of ERAS in Hu′nan Province,Hu′nan Province,Changsha 410005,China)
出处 《中国当代医药》 CAS 2021年第25期13-17,共5页 China Modern Medicine
基金 湖南省围术期加速康复麻醉临床医学研究中心资助项目(2018SK7001) 湖南省卫生健康委科研课题(202104111604)。
关键词 氢吗啡酮 舒芬太尼 静脉 镇痛 META分析 Hydromorphone Sufentanil Intravenous Analgesia Meta-analysis
  • 相关文献

参考文献11

二级参考文献66

  • 1吴蔚宇,徐美英.开胸手术后疼痛综合征及诊治[J].继续医学教育,2006,20(32):63-65. 被引量:11
  • 2林娜,李丽,李天佐,张炳熙.功能性鼻内镜手术后疼痛的临床观察[J].临床麻醉学杂志,2007,23(3):239-240. 被引量:18
  • 3庄心良,曾因明,陈伯銮.现代麻醉学[M].第3版.北京:人民卫生出版社,2004.1052.
  • 4Felden L,Walter C,Harder S,et al.Comparative Clinical Effects of Hydromorphone and Morphine[J].Br J Anaesth,2011,107(3):319-328.
  • 5Hong D, Flood P, Diaz G. The side effects of morphine and hydromorphone patient-controlled analgesia[J]. Anesth- Analg, 2008, 107(4): 1384-1389.
  • 6Patel S, Roshan VR, Lee KC, et al. A myoclonic reaction with low-dose hydromorphone[J]. Ann Pharmacother, 2006, 40(11): 2068- 2070.
  • 7Bruera E,Sloan P,Mount B,et al.A randomized,double-blind,double-dummy,crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain.Canadian Palliative Care Clinical Trials Group[J].J Clin Oncol,1996,14(5):1713-1717.
  • 8Chandler SW,Trissel LA,Weinstein SM.Combined administration of opioids with selected drugs to manage pain and other cancer symptoms:initial safety screening for compatibility[J].J Pain Symptom Manage,1996,12(3):168-171.
  • 9Junker U,Figge V.Controlled-release hydromorphone in elderly patients with severe pain of different etiologies.Results of an observational study[J].MMW Fortschr Med,2005,147 Suppl 3:91-96.
  • 10Pergolizzi J,Bger RH,Budd K,et al.Opioids and the management of chronic severe pain in the elderly:consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization StepⅢopioids(buprenorphine,fentanyl,hydromorphone,methadone,morphine,oxycodone)[J].Pain Pract,2008,8(4):287-313.

共引文献109

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部